According to the core target information, MAPK3, AKT1, HSP90AA1, ESR1, RELA, TP53, STAT3, IL2, NFKB1, LCK, JUN, MAPK14, EGFR, ADRBK1, PRKCD, PRKCA, and PRKCZ, which ranked high, might be key targets for the treatment of AD. Here, PRKCA is linked to Alzheimer disease.